New Validation and Clinical Outcome Data From Several Studies Using Nanosphere’s Infectious Disease Tests to be Presented at ECCMID 2014

[GlobeNewswire] – NORTHBROOK, Ill. — Nanosphere, Inc. , a company enhancing medicine through targeted molecular diagnostics, today announced that new validation and clinical outcome data for select Verigene(R) multiplex … more

View todays social media effects on NSPH

View the latest stocks trending across Twitter. Click to view dashboard

See who Nanosphere is hiring next, click here to view